Article

Pharma USA 2023: Digital Therapeutics and Pharma

Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.

Tracey Dodenhoff, CEO of Medly Therapeutics, discusses her company's heart failure app and why pharma should consider prescription digital therapeutics among their offerings.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Gen Li
Related Content
Risk Contracting When Orphan Disease Space is Crowded
August 14th 2025

Risk Contracting When Orphan Disease Space is Crowded

Ira Studin, PhD
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 14th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
Magellan AI Identifies and Optimizes Molecules Beyond the Public Domain
August 14th 2025

Magellan AI Identifies and Optimizes Molecules Beyond the Public Domain

Don Tracy, Associate Editor
Peter Ax, UpScriptHealth
August 14th 2025

Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals

Miranda Schmalfuhs
GAIN Therapeutics Ramps Up for Next Big Step in Parkinson’s Drug Development
August 14th 2025

GAIN Therapeutics Ramps Up for Next Big Step in Parkinson’s Drug Development

Don Tracy, Associate Editor
Early Trial Success Signals Promise for GT-02287 in Parkinson’s Disease Treatment
August 14th 2025

Early Trial Success Signals Promise for GT-02287 in Parkinson’s Disease Treatment

Don Tracy, Associate Editor